Close
  Indian J Med Microbiol
 

Table 3 :Initial empiric therapy for HAP/VAP in patients with no known risk factors for MDR pathogens, early onset, and any disease severity (adapted from ATS guidelines; 2005)

Table 3 :Initial empiric therapy for HAP/VAP in patients with no known risk factors for MDR pathogens, early onset, and any disease severity (adapted from ATS guidelines; 2005)